
Revolution Medicines (NASDAQ:RVMD) brought in sales totaling $7.58 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.44%, resulting in a loss of $57.65 million. Revolution Medicines collected $9.46 million in revenue during Q4, but reported earnings showed a $52.68 million loss.